Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
First Ascent Biomedical Nabs $6M Investment to Advance Functional Precision Medicine Platform
The firm will use the funds to establish a commercial lab and continue advancing its AI- and sequencing-based platform for personalizing cancer treatment.
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Liquid Biopsy Developer Oxford Cancer Analytics Raises $11M
The company, which is based in England and has operations in Canada, is developing a liquid biopsy test for lung cancer detection.
Biomarker-Targeted Therapy in 2025: Precise Patient Selection, MRD, Antibody-Drug Conjugates
Premium
The already crowded field of biomarker-targeted drugs is poised to only get busier with new biomarkers, ADCs, and cancer vaccines.
Tempus, Genialis Partner to Develop RNA-Based Cancer Biomarker Algorithms
Genialis will use Tempus' multimodal dataset to develop new RNA-based algorithms for a variety of cancers.